Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Dtg Nrtis'

Dtg Nrtis published presentations and documents on DocSlides.

Superior Efficacy of Dolutegravir (DTG) Plus

Superior Efficacy of Dolutegravir (DTG) Plus

  • celsa-spraggs
  • 0 Slides

2 Nucleoside Reverse Transcriptase Inhibitors (NR...

DTG vs LPV/r (DAWNING): Efficacy

DTG vs LPV/r (DAWNING): Efficacy

  • winnie
  • 12 Slides

by Baseline NRTI Resistance . and Second-Line NRTI...

Dolutegravir + 2 NRTIs versus Darunavir + RTV + 2 NRTIs

Dolutegravir + 2 NRTIs versus Darunavir + RTV + 2 NRTIs

  • roxanne
  • 9 Slides

FLAMINGO. Dolutegravir + 2 NRTIs versus Darunavir ...

DOR + 2 NRTIs vs. DRV + RTV + 2 NRTIs

DOR + 2 NRTIs vs. DRV + RTV + 2 NRTIs

  • maximus
  • 8 Slides

DRIVE FORWARD. Doravirine. + 2 NRTIs vs. Darunavi...

LPV-RTV + 3TC vs. LPV-RTV + 2 NRTIs in

LPV-RTV + 3TC vs. LPV-RTV + 2 NRTIs in

  • lucy
  • 7 Slides

Virologically. Suppressed. OLE Trial. LPV-RTV + ....

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials

  • luanne-stotts
  • 31 Slides

Progressive rises in weight and clinical obesity ...

DTG + 3TC versus DTG + TDF-FTC as Initial ART

DTG + 3TC versus DTG + TDF-FTC as Initial ART

  • della
  • 17 Slides

GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC

  • iris
  • 11 Slides

ADVANCE. . Design. Primary endpoint. Proportion ...

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV

  • kylo
  • 31 Slides

Andrew Hill, Francois Venter, Eric . Delaporte. , ...

Updated WHO Treatment Guidelines &

Updated WHO Treatment Guidelines &

  • mitsue-stanley
  • 0 Slides

Data . from other . cohorts and . regions to guid...

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

  • myesha-ticknor
  • 0 Slides

Martina Penazzato MD, PhD. Paediatric lead, HIV D...

CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure

CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure

  • brown
  • 34 Slides

Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...

DTG-Based Regimens Are Active in INI-Naive Patients With a

DTG-Based Regimens Are Active in INI-Naive Patients With a

  • trish-goza
  • 14 Slides

Jim Demarest. ,. 1. Mark Underwood,. 2. Marty S...

Switch to DTG/ABC/3TC

Switch to DTG/ABC/3TC

  • karlyn-bohler
  • 10 Slides

STRIIVING . Study. Design. Endpoints. Primary: pr...

Switch to DTG/3TC TANGO Design

Switch to DTG/3TC TANGO Design

  • lam
  • 10 Slides

Endpoints. Primary: proportion of patients with HI...

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

  • jasmine
  • 15 Slides

–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...

DTG/3TC 1st line (GEMINI)

DTG/3TC 1st line (GEMINI)

  • oryan
  • 37 Slides

ARV . strategies. DOR > DRV/r 1st line. (DRIVE-...

SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN

SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN

  • jacey
  • 17 Slides

1. ViiV Healthcare, Brentford, UK; . 2. Centre Hos...

ART Resistance and Second Line Regimens

ART Resistance and Second Line Regimens

  • calandra-battersby
  • 0 Slides

Learning Objectives. Understand when to switch to...

Lopinavir -RTV + NVP +

Lopinavir -RTV + NVP +

  • thomas
  • 6 Slides

2 NRTIs in Treatment-Experienced. M97-765 Trial. L...

Optimizing HIV treatment

Optimizing HIV treatment

  • anderson
  • 26 Slides

Professor Francois Venter. Ezintsha, University of...

A nti- R etroviral T herapy Basics

A nti- R etroviral T herapy Basics

  • caroline
  • 85 Slides

E Duke. https://www.hiv.uw.edu/page/treatment/drug...

Switch NRTIs to Tenofovir DF-Emtricitabine or Abacavir-Lamivudine

Switch NRTIs to Tenofovir DF-Emtricitabine or Abacavir-Lamivudine

  • kylie
  • 7 Slides

STEAL. Switch NRTIs to Tenofovir DF-Emtricitabine ...

ART in Women and Contraception: InSTIs

ART in Women and Contraception: InSTIs

  • olivia-moreira
  • 52 Slides

ART in Women and Contraception: InSTIs , Comorbi...

Switching Antiretroviral Therapy (ART) in Your African American Patients: When and How

Switching Antiretroviral Therapy (ART) in Your African American Patients: When and How

  • taylor
  • 29 Slides

Supported by an educational grant from Gilead Scie...

Comparison of INSTI vs PI

Comparison of INSTI vs PI

  • conchita-marotz
  • 17 Slides

FLAMINGO. GS-236-0103. ACTG . A5257. WAVES. . De...

Comparison of INSTI vs PI

Comparison of INSTI vs PI

  • conchita-marotz
  • 6 Slides

FLAMINGO. GS-236-0103. ACTG A5257. WAVES. ARIA . ...

Projecting the Impact of

Projecting the Impact of

  • marina-yarberry
  • 0 Slides

Generic. HIV . Drugs. on 90-90-90. Esteban Burr...

10 th International Pediatric HIV Workshop

10 th International Pediatric HIV Workshop

  • luanne-stotts
  • 0 Slides

and 22. nd. International AIDS Conference . Sele...

1 Fundación Huésped, Buenos Aires, Argentina;

1 Fundación Huésped, Buenos Aires, Argentina;

  • aaron
  • 0 Slides

2. Instituto Nacional de Ciencias Médicas y Nutr...

New regimen for $75 a year

New regimen for $75 a year

  • tawny-fly
  • 0 Slides

New pricing agreement will speed up access to gen...

Session - Safety of DTG in Pregnancy: Late Breaking Findings, Interpretations, Implications

Session - Safety of DTG in Pregnancy: Late Breaking Findings, Interpretations, Implications

  • liane-varnes
  • 0 Slides

July 24 2018 . Overview on Safety of HIV Treatmen...

Potential safety issue affecting women living with HIV using

Potential safety issue affecting women living with HIV using

  • luanne-stotts
  • 0 Slides

dolutegravir. at the time of conception. Meg Doh...

10 th International Pediatric HIV Workshop

10 th International Pediatric HIV Workshop

  • faustina-dinatale
  • 0 Slides

and 22. nd. International AIDS Conference . Sele...

C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. Myer, J. Kaboggoza, B. Simmons, L. Else, C. Heiberg, C. Waitt, S.

C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. Myer, J. Kaboggoza, B. Simmons, L. Else, C. Heiberg, C. Waitt, S.

  • liane-varnes
  • 12 Slides

C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. ...

Dolutegravir monotherapy

Dolutegravir monotherapy

  • alexa-scheidler
  • 15 Slides

Dolutegravir monotherapy vs. dolutegravir/ abac...

Heather Watts MD Director of HIV Prevention, Program Quality Team

Heather Watts MD Director of HIV Prevention, Program Quality Team

  • alida-meadow
  • 22 Slides

Heather Watts MD Director of HIV Prevention, Pro...

1 Queen Mary University, London, United Kingdom;

1 Queen Mary University, London, United Kingdom;

  • trish-goza
  • 15 Slides

1 Queen Mary University, London, United Kingdom; ...

What’s New in WHO Treatment Guidelines

What’s New in WHO Treatment Guidelines

  • aaron
  • 28 Slides

July 23 2018 . What We Know About Safety Signals ...

Comparison of INSTI vs EFV

Comparison of INSTI vs EFV

  • mediumgeneral
  • 12 Slides

STARTMRK. GS-US-236-0102 . SINGLE. Walmsley. S. N...

Copyright © 2024 DocSlides. All Rights Reserved